Willis Towers Watson Publ... (WTW)
294.42
-12.64 (-4.12%)
At close: Apr 25, 2025, 10:57 AM
Willis Towers Watson Public Revenue Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Health, Wealth and Career Revenue | 1.34B | 1.27B | 1.35B | 1.44B | 1.3B | 1.61B | 1.3B | 1.74B | 1.18B | 1.17B | 1.26B |
| Health, Wealth and Career Revenue Growth | +5.49% | -5.76% | -6.04% | +10.94% | -19.63% | +24.04% | -25.30% | +47.96% | +0.43% | -6.68% | n/a |
| Risk and Broking Revenue | 943M | 982M | 981M | 1.08B | 858M | 903M | 907M | 956M | 767M | 854M | 894M |
| Risk and Broking Revenue Growth | -3.97% | +0.10% | -9.17% | +25.87% | -4.98% | -0.44% | -5.13% | +24.64% | -10.19% | -4.47% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International Revenue | 9.37B | 8.74B | 8.8B | 9.2B | 8.89B | 8.38B | 8.1B | 7.79B | 1.07B | 2.43B | 2.27B | 2.17B | 2.12B |
| International Revenue Growth | +7.20% | -0.74% | -4.28% | +3.37% | +6.21% | +3.46% | +3.85% | +629.87% | -56.09% | +7.18% | +4.71% | +2.02% | n/a |
| Ireland Revenue | 118M | 130M | 1.63B | 157M | 144M | 138M | 107M | 92M | n/a | n/a | n/a | n/a | n/a |
| Ireland Revenue Growth | -9.23% | -92.03% | +939.49% | +9.03% | +4.35% | +28.97% | +16.30% | n/a | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue | 2.63B | 2.41B | 197M | 2.63B | 2.59B | 2.48B | 2.46B | 2.16B | n/a | n/a | n/a | n/a | n/a |
| Rest Of World Revenue Growth | +9.03% | +1124.87% | -92.50% | +1.31% | +4.52% | +0.81% | +13.63% | n/a | n/a | n/a | n/a | n/a | n/a |
| United Kingdom Revenue | 1.72B | 1.56B | 2.55B | 1.92B | 1.93B | 1.93B | 1.81B | 2.24B | n/a | n/a | n/a | n/a | n/a |
| United Kingdom Revenue Growth | +10.24% | -38.66% | +32.71% | -0.72% | +0.42% | +6.12% | -18.83% | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 5.01B | 4.76B | 4.62B | 4.65B | 4.37B | 3.97B | 3.82B | 3.4B | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | +5.27% | +3.01% | -0.62% | +6.41% | +10.08% | +3.90% | +12.55% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.13B | 29M | -21M | 56M | 42M | -29M | -25M | 46M | 45M | 46M | 72M | 57M | 52M | 56M | 59M | 59M | 59M | 60M | 59M | 57M | 61M | 59M | 63M | 61M | 57M | 58M | 64M | 64M | 302M | n/a | n/a | n/a | 302M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling, General, and Administrative Revenue Growth | +7258.62% | -238.10% | -137.50% | +33.33% | -244.83% | +16.00% | -154.35% | +2.22% | -2.17% | -36.11% | +26.32% | +9.62% | -7.14% | -5.08% | 0.00% | 0.00% | -1.67% | +1.69% | +3.51% | -6.56% | +3.39% | -6.35% | +3.28% | +7.02% | -1.72% | -9.38% | 0.00% | -78.81% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |